FAM111B and ovarian carcinoma: We herein observed that FAM111B knockdown attenuated tumor growth both in vitro and in vivo in ovarian cancer, with results aligning with a previous study that illustrated the impact of FAM111B suppression on tumor growth, G1/S phase cell-cycle arrest, and apoptosis in ovarian cancer [18].